|
A-375
|
IC50 |
|
Cytotoxicity in human A375 cells
Cytotoxicity in human A375 cells
|
[PMID: 28793973]
|
|
A-431
|
IC50 |
|
Inhibition of EGFR in human A431 cells
Inhibition of EGFR in human A431 cells
|
[PMID: 1479375]
|
|
A549
|
IC50 |
> 10 x 10 -5 M
Compound: 7
|
Cytotoxicity against human A549 cells after 72 hrs by XTT assay
Cytotoxicity against human A549 cells after 72 hrs by XTT assay
|
[PMID: 20619940]
|
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
Cytotoxicity against human A549 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 28165740]
|
|
A549
|
IC50 |
> 20 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 21106454]
|
|
B16
|
IC50 |
|
Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs
Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs
|
[PMID: 19615910]
|
|
B16
|
IC50 |
|
Cytotoxicity against mouse B16 cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against mouse B16 cells assessed as cell viability after 48 hrs by MTT assay
|
[PMID: 25659770]
|
|
B16-4A5
|
IC50 |
|
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs
|
[PMID: 20189399]
|
|
B16-4A5
|
IC50 |
|
Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability after 68 hrs by WST8 assay
Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability after 68 hrs by WST8 assay
|
[PMID: 19615910]
|
|
BEAS-2B
|
IC50 |
|
Cytotoxicity against human BEAS-2B cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against human BEAS-2B cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 33231455]
|
|
BGC-823
|
IC50 |
|
Cytotoxicity against human BGC-823 cells measured after 48 hrs by MTT assay
Cytotoxicity against human BGC-823 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
BT-549
|
IC50 |
|
Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
Cytotoxicity against human BT549 cells after 48 hrs by SRB assay
|
[PMID: 28165740]
|
|
BV-2
|
IC50 |
|
Anti-inflammatory activity in mouse BV-2 cells assessed as reduction in LPS-induced NO production
Anti-inflammatory activity in mouse BV-2 cells assessed as reduction in LPS-induced NO production
|
[PMID: 37683361]
|
|
BV-2
|
IC50 |
|
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced PGE2 production pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced PGE2 production pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
|
[PMID: 37683361]
|
|
BV-2
|
IC50 |
|
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced COX-2 expression pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced COX-2 expression pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
|
[PMID: 37683361]
|
|
BV-2
|
IC50 |
|
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitrite production after 24 hrs by Griess assay
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitrite production after 24 hrs by Griess assay
|
[PMID: 28165740]
|
|
BV-2
|
IC50 |
|
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced IL-1beta secretion pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced IL-1beta secretion pretreated for 2 hrs followed stimulated with LPS for 22 hrs by ELISA analysis
|
[PMID: 37683361]
|
|
BV-2
|
IC50 |
|
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced IL-6 pre-treated for 2 hrs followed stimulated with LPS for 22 hrs
Anti-inflammatory activity against mouse BV-2 cells assessed as inhibition of LPS-induced IL-6 pre-treated for 2 hrs followed stimulated with LPS for 22 hrs
|
[PMID: 37683361]
|
|
CHO-K1
|
IC50 |
|
Cytotoxicity against CHO-K1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against CHO-K1 cells assessed as reduction in cell viability after 24 hrs by MTT assay
|
[PMID: 33231455]
|
|
CWR22R
|
IC50 |
|
Antiproliferative activity against human 22Rv1 cells incubated up to 144 hrs by Coulter particle count and size analyzer
Antiproliferative activity against human 22Rv1 cells incubated up to 144 hrs by Coulter particle count and size analyzer
|
[PMID: 22789812]
|
|
Ca9-22
|
IC50 |
> 20 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human Ca9-22 cells by MTT assay
Cytotoxicity against human Ca9-22 cells by MTT assay
|
[PMID: 21106454]
|
|
HCC1937
|
IC50 |
|
Cytotoxicity against human HCC1937 cells measured after 48 hrs by MTT assay
Cytotoxicity against human HCC1937 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
HCT-116
|
IC50 |
|
Cytotoxicity against human HCT-116 cells measured after 48 hrs by MTT assay
Cytotoxicity against human HCT-116 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
HEK293
|
IC50 |
|
Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
|
[PMID: 18533708]
|
|
HEK293
|
IC50 |
|
Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol
|
[PMID: 18533708]
|
|
HEK293
|
IC50 |
|
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
|
[PMID: 20731357]
|
|
HEK293
|
IC50 |
|
Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay
Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in gadolinium-induced calcium entry after 30 mins by fluo-4 dye based fluorescence assay
|
[PMID: 30943030]
|
|
HL-60
|
IC50 |
|
Antioxidant activity in human HL60 cells assessed as reduction of cytochrome-c release
Antioxidant activity in human HL60 cells assessed as reduction of cytochrome-c release
|
[PMID: 10650074]
|
|
HT-29
|
IC50 |
> 10 x 10 -5 M
Compound: 7
|
Cytotoxicity against human HT-29 cells after 72 hrs by XTT assay
Cytotoxicity against human HT-29 cells after 72 hrs by XTT assay
|
[PMID: 20619940]
|
|
HUVEC
|
IC50 |
10 μM
Compound: 5, Kaempferol
|
Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
|
10.1007/s00044-012-0353-y
|
|
HeLa
|
IC50 |
|
Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA
Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA
|
[PMID: 19942440]
|
|
HeLa
|
IC50 |
> 10 x 10 -5 M
Compound: 7
|
Cytotoxicity against human HeLa cells after 72 hrs by XTT assay
Cytotoxicity against human HeLa cells after 72 hrs by XTT assay
|
[PMID: 20619940]
|
|
Hep 3B2
|
IC50 |
17.74 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 21106454]
|
|
HepG2
|
EC50 |
7.74 μM
Compound: Kaempferol
|
Antioxidant activity in human HepG2 cells assessed as decrease in fluorescence level after 2.5 hrs measured every 5 mins for 1 hr by DCFH-DA staining based fluorescence assay
Antioxidant activity in human HepG2 cells assessed as decrease in fluorescence level after 2.5 hrs measured every 5 mins for 1 hr by DCFH-DA staining based fluorescence assay
|
[PMID: 26974372]
|
|
HepG2
|
IC50 |
|
Anti-inflammatory activity against TNFalpha-induced human HepG2 cells assessed as inhibition of NF-kappaB activity pre-indubated for 1 hr followed by TNFalpha treatment measured for 5 hrs by luciferase based assay
Anti-inflammatory activity against TNFalpha-induced human HepG2 cells assessed as inhibition of NF-kappaB activity pre-indubated for 1 hr followed by TNFalpha treatment measured for 5 hrs by luciferase based assay
|
[PMID: 37683361]
|
|
HepG2
|
IC50 |
|
Inverse agonist activity at human GAL4-DBD-fused ERRalpha-LBD transfected in human HepG2 cells assessed as disruption of interaction with PGC-1alpha after 24 hrs by dual luciferase reporter gene assay
Inverse agonist activity at human GAL4-DBD-fused ERRalpha-LBD transfected in human HepG2 cells assessed as disruption of interaction with PGC-1alpha after 24 hrs by dual luciferase reporter gene assay
|
[PMID: 23656512]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
HepG2
|
IC50 |
> 20 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 21106454]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 21726077]
|
|
Huh-7
|
CC50 |
|
Cytotoxicity against human Huh7.5.1 cells by MTT assay
Cytotoxicity against human Huh7.5.1 cells by MTT assay
|
[PMID: 22445328]
|
|
J774.2
|
IC50 |
|
Cytotoxicity against BALB/c mouse J774.2 cells after 72 hrs by trypan blue assay
Cytotoxicity against BALB/c mouse J774.2 cells after 72 hrs by trypan blue assay
|
[PMID: 19489596]
|
|
Jurkat
|
IC50 |
10.5 μM
Compound: Kaempferol
|
Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method
Inhibition of chymotrypsin-like activity of purified human 20S proteasome expressed in human Jurkat cells assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 2 hrs by fluorescence based method
|
[PMID: 30776692]
|
|
Jurkat
|
IC50 |
11 μM
Compound: Kaempferol
|
Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method
Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Leu-AMC as substrate after 24 hrs by fluorescence based method
|
[PMID: 30776692]
|
|
L929
|
EC50 |
20 μM
Compound: kaempferol
|
Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining
Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining
|
[PMID: 9287415]
|
|
L929
|
EC50 |
25 μM
Compound: kaempferol
|
Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay
Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay
|
[PMID: 9287415]
|
|
MCF7
|
IC50 |
50 μM
Compound: Kaempferol
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 6 days by SRB assay
|
[PMID: 33257172]
|
|
MCF7
|
IC50 |
|
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells measured after 48 hrs by MTT assay
|
[PMID: 33979163]
|
|
MCF7
|
IC50 |
> 20 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 21106454]
|
|
MDA-MB-231
|
IC50 |
> 20 μg/mL
Compound: Kaempferol
|
Cytotoxicity against human MDA-MB-231 cells by MTT assay
Cytotoxicity against human MDA-MB-231 cells by MTT assay
|
[PMID: 21106454]
|
|
MDCK
|
CC50 |
581.3 μM
Compound: Kaempferol
|
Cytotoxicity against MDCK cells
Cytotoxicity against MDCK cells
|
[PMID: 25096296]
|
|
MDCK
|
CC50 |
|
Cytotoxicity against MDCK cells after 48 hrs by MTT assay
Cytotoxicity against MDCK cells after 48 hrs by MTT assay
|
[PMID: 19729316]
|
|
MDCK
|
EC50 |
|
Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
|
[PMID: 19729316]
|
|
MDCK
|
EC50 |
|
Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect
|
[PMID: 19729316]
|
|
MDCK
|
IC50 |
|
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining
|
[PMID: 21354800]
|
|
MV4-11
|
GI50 |
|
Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay
Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay
|
[PMID: 23411073]
|
|
Monocyte
|
IC50 |
2.7 x 10 -6 M
Compound: kaempferol
|
Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs
|
[PMID: 8882428]
|
|
Monocyte
|
IC50 |
20 μM
Compound: Kaempferol
|
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
|
[PMID: 10096854]
|
|
Osteoclast
|
IC50 |
1.6 μM
Compound: kaempferol
|
Induction of mouse osteoclast apoptosis
Induction of mouse osteoclast apoptosis
|
[PMID: 17994703]
|
|
P388
|
ED50 |
6.7 μg/mL
Compound: Kaempferol
|
Cytotoxicity against mouse P388 cells
Cytotoxicity against mouse P388 cells
|
[PMID: 3404159]
|
|
Peritoneal macrophage
|
IC50 |
|
Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method
Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method
|
[PMID: 27955927]
|
|
Platelet
|
IC50 |
3.55 μg/mL
Compound: Kaempferol
|
Antiaggregatory activity in human platelets assessed as inhibition of collagen-induced platelet aggregation by aggregometry
Antiaggregatory activity in human platelets assessed as inhibition of collagen-induced platelet aggregation by aggregometry
|
[PMID: 21106454]
|
|
Platelet
|
IC50 |
> 50 μg/mL
Compound: Kaempferol
|
Antiaggregatory activity in human platelets assessed as inhibition of thrombin-induced platelet aggregation by aggregometry
Antiaggregatory activity in human platelets assessed as inhibition of thrombin-induced platelet aggregation by aggregometry
|
[PMID: 21106454]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in LPS-stimulated IL-6 mRNA level incubated for 3 hrs by RT-qPCR analysis
Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in LPS-stimulated IL-6 mRNA level incubated for 3 hrs by RT-qPCR analysis
|
[PMID: 37683361]
|
|
RAW264.7
|
IC50 |
13.4 μM
Compound: 5; kp19
|
Inhibition of LPS-stimulated nitric oxide production in mouse RAW264.7 cells by Greiss method
Inhibition of LPS-stimulated nitric oxide production in mouse RAW264.7 cells by Greiss method
|
[PMID: 27955927]
|
|
RAW264.7
|
IC50 |
13.4 μM
Compound: Kaempferol
|
Inhibition of LPS-stimulated nitric oxide production in rat RAW264.7 cells pretreated for 2 hrs followed by LPS-stimulation after 16 hrs by Griess assay
Inhibition of LPS-stimulated nitric oxide production in rat RAW264.7 cells pretreated for 2 hrs followed by LPS-stimulation after 16 hrs by Griess assay
|
[PMID: 28662961]
|
|
RAW264.7
|
IC50 |
|
Anti-inflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production by ELISA analysis
Anti-inflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production by ELISA analysis
|
[PMID: 37683361]
|
|
RAW264.7
|
IC50 |
|
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells measured after 16 hrs
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells measured after 16 hrs
|
[PMID: 27955927]
|
|
RAW264.7
|
IC50 |
|
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells by Greiss method
Inhibition of LPS/INF-gamma-stimulated nitric oxide production in mouse RAW264.7 cells by Greiss method
|
[PMID: 27955927]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method
|
[PMID: 21353543]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs
Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs
|
[PMID: 21353543]
|
|
RAW264.7
|
IC50 |
< 15 μM
Compound: kaempherol
|
Inhibition of COX2 mRNA expression in mouse RAW264.7 cells
Inhibition of COX2 mRNA expression in mouse RAW264.7 cells
|
[PMID: 16038536]
|
|
RS4-11
|
GI50 |
|
Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay
Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay
|
[PMID: 23411073]
|
|
SK-MEL-2
|
IC50 |
|
Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay
|
[PMID: 28165740]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay
|
[PMID: 28165740]
|
|
Sf21
|
IC50 |
|
Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay
Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay
|
[PMID: 17378609]
|
|
THP-1
|
IC50 |
|
Anti-inflammatory activity in human THP-1 cells assessed as inhibition of LPS-stimulated NO production by ELISA analysis
Anti-inflammatory activity in human THP-1 cells assessed as inhibition of LPS-stimulated NO production by ELISA analysis
|
[PMID: 37683361]
|
|
Vero
|
CC50 |
91.5 μg/mL
Compound: kaempferol
|
Cytotoxicity against african green monkey Vero cells
Cytotoxicity against african green monkey Vero cells
|
[PMID: 1338212]
|